Paper36856424
Colistin Enhances Rifampicin's Antimicrobial Action in Colistin-Resistant Pseudomonas aeruginosa Biofilms.
Armengol E and 7 others. Antimicrob Agents Chemother, 2023. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Colistin Enhances Rifampicin's Antimicrobial Action in Colistin-Resistant Pseudomonas aeruginosa Biofilms. Papers, record 36856424. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36856424
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Colistin Enhances Rifampicin's Antimicrobial Action in Colistin-Resistant Pseudomonas aeruginosa Biofilms.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colistin | Major topic |
| Pseudomonas Infections | Major topic |
| Humans | |
| Pseudomonas aeruginosa | |
| Rifampin | |
| Anti-Bacterial Agents | |
| Biofilms | |
| Microbial Sensitivity Tests |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33214718 | Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis. | Nat Rev Microbiol | 2021 | https://conductscience.org/library/papers/33214718 | PubMed |
| 2 | 32784516 | Polymyxins and Bacterial Membranes: A Review of Antibacterial Activity and Mechanisms of Resistance. | Membranes (Basel) | 2020 | https://conductscience.org/library/papers/32784516 | PubMed |
| 3 | 31977044 | Effect of colistin-based antibiotic combinations on the eradication of persister cells in Pseudomonas aeruginosa. | J Antimicrob Chemother | 2020 | https://conductscience.org/library/papers/31977044 | PubMed |
| 4 | 18358794 | Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. | J Cyst Fibros | 2008 | https://conductscience.org/library/papers/18358794 | PubMed |
| 5 | 34177826 | 2-Heptylcyclopropane-1-Carboxylic Acid Disperses and Inhibits Bacterial Biofilms. | Front Microbiol | 2021 | https://conductscience.org/library/papers/34177826 | PubMed |
| 6 | 17682994 | Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains. | Clin Infect Dis | 2007 | https://conductscience.org/library/papers/17682994 | PubMed |
| 7 | 31372011 | Efficacy of combinations of colistin with other antimicrobials involves membrane fluidity and efflux machinery. | Infect Drug Resist | 2019 | https://conductscience.org/library/papers/31372011 | PubMed |
| 8 | 28368216 | An overview of antimicrobial peptides and the latest advances in their development. | Expert Opin Biol Ther | 2017 | https://conductscience.org/library/papers/28368216 | PubMed |
| 9 | 19231985 | Multidrug resistance in bacteria. | Annu Rev Biochem | 2009 | https://conductscience.org/library/papers/19231985 | PubMed |
| 10 | 28874373 | Hyperbaric Oxygen Sensitizes Anoxic Pseudomonas aeruginosa Biofilm to Ciprofloxacin. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/28874373 | PubMed |
| 11 | 30803159 | Optimization of colistin dosing regimen for cystic fibrosis patients with chronic Pseudomonas aeruginosa biofilm lung infections. | Pediatr Pulmonol | 2019 | https://conductscience.org/library/papers/30803159 | PubMed |
| 12 | 33821795 | Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane. | Elife | 2021 | https://conductscience.org/library/papers/33821795 | PubMed |
| 13 | 11348676 | A panel of Tn7-based vectors for insertion of the gfp marker gene or for delivery of cloned DNA into Gram-negative bacteria at a neutral chromosomal site. | J Microbiol Methods | 2001 | https://conductscience.org/library/papers/11348676 | PubMed |
| 14 | 18312276 | Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. | Mol Microbiol | 2008 | https://conductscience.org/library/papers/18312276 | PubMed |
| 15 | 30376071 | Triple combination of meropenem, colistin and tigecycline was bactericidal in a dynamic model despite mere additive interactions in chequerboard assays against carbapenemase-producing Klebsiella pneumoniae isolates. | J Antimicrob Chemother | 2019 | https://conductscience.org/library/papers/30376071 | PubMed |
| 16 | 19243444 | Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa. | FEMS Microbiol Rev | 2009 | https://conductscience.org/library/papers/19243444 | PubMed |
| 17 | 30683887 | Drug combinations: a strategy to extend the life of antibiotics in the 21st century. | Nat Rev Microbiol | 2019 | https://conductscience.org/library/papers/30683887 | PubMed |
| 18 | 30711384 | Hyperbaric oxygen treatment increases killing of aggregating Pseudomonas aeruginosa isolates from cystic fibrosis patients. | J Cyst Fibros | 2019 | https://conductscience.org/library/papers/30711384 | PubMed |
| 19 | 23459479 | Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23459479 | PubMed |
| 20 | 33672663 | The History of Colistin Resistance Mechanisms in Bacteria: Progress and Challenges. | Microorganisms | 2021 | https://conductscience.org/library/papers/33672663 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42967945 | Characterization and treatment of polymicrobial biofilms in prosthetic joint infections. | Appl Microbiol Biotechnol | 2026 | https://conductscience.org/library/papers/42967945 | PubMed |
| 42774664 | The activity of a new bicyclic peptide, PLP-3, against colistin-resistant Pseudomonas aeruginosa biofilms. | Biofilm | 2026 | https://conductscience.org/library/papers/42774664 | PubMed |
| 41900883 | Chemical Characterization and Evaluation of Antimicrobial, Antioxidant, and Synergistic Activities of Teucrium polium L.: An Integrated Experimental and In Silico Approach. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41900883 | PubMed |
| 41312994 | Synergistic activity of rifampicin and polymyxin B against intracellular Gram-negative ESKAPE pathogens involves bacterial membrane alterations and enhanced oxidative damages. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/41312994 | PubMed |
| 40558147 | Outbreak of NDM-5-Producing Proteus mirabilis During the COVID-19 Pandemic in an Argentine Hospital. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/40558147 | PubMed |
| 39597505 | Pseudomonas aeruginosa in the Frontline of the Greatest Challenge of Biofilm Infection-Its Tolerance to Antibiotics. | Microorganisms | 2024 | https://conductscience.org/library/papers/39597505 | PubMed |
| 39445123 | Synergistic combinations of novel polymyxins and rifampicin with improved eradication of colistin-resistant Pseudomonas aeruginosa biofilms. | Biofilm | 2024 | https://conductscience.org/library/papers/39445123 | PubMed |
| 39402397 | Biofilm matrix: a multifaceted layer of biomolecules and a defensive barrier against antimicrobials. | Arch Microbiol | 2024 | https://conductscience.org/library/papers/39402397 | PubMed |
| 39061324 | Impact of Growth Conditions on High-Throughput Identification of Repurposing Drugs for Pseudomonas aeruginosa Cystic Fibrosis Lung Infections. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39061324 | PubMed |
| 38668338 | A Study of the Synergistic Effects of Essential Oils from Origanum compactum and Origanum elongatum with Commercial Antibiotics against Highly Prioritized Multidrug-Resistant Bacteria for the World Health Organization. | Metabolites | 2024 | https://conductscience.org/library/papers/38668338 | PubMed |
| 38258128 | Antibiotics against Pseudomonas aeruginosa on Human Skin Cell Lines: Determination of the Highest Non-Cytotoxic Concentrations with Antibiofilm Capacity for Wound Healing Strategies. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38258128 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36856424
GET https://conductscience.org/api/papers/v1/36856424/references?page=2